Multiple studies have shown that in SARS-CoV-2 patients with cardiovascular disease, elevated markers of thrombo-inflammatory activation like CRP, IL-6, and troponins are predictors of mortality (25). This evidence concerns the gene CRP and cardiovascular disorder.